Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual methadone for cancer-related procedural pain in inpatients
ISRCTN72738824Phase 2Terminated
- Sponsor
- Alberta Health Services
- Start
- Jun 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of methadone in breakthrough pain, sponsored by Alberta Health Services. Primary endpoints: Feasibility of recruitment, Feasibility of dose titration and 3 more. Started Jun 2006; status: terminated.
02
Drugs
methadone
03
Conditions
breakthrough pain
Beyond the preview
Go deeper on ISRCTN72738824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN72738824.